Will the scientific data relating to COVID-19 vaccines be made public by the European Medicines Agency?

Will the scientific data relating to COVID-19 vaccines be made public by the European Medicines Agency?

Last update: 06/01/2021

All of the scientific data will be publicly accessible via the European Medicines Agency website. After a vaccine is approved, information about the product (leaflet and summary of product characteristics (SmPC)), the European public assessment report (EPAR), the risk management plan (RMP) and clinical trial data will be available. Once the product is marketed, data on side effects will also be available.